Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existence

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Rebetz, Johan ^a   Na, Manli ^a,c   Su, Changqing ^c   Holmqvist, Bo ^a   Edqvist, Anna ^a   Nyberg, Cecilia ^b   Widegren, Bengt ^a   Salford, Leif G ^a   Sjögren, Hans Olov ^a   Arnberg, Niklas ^b   Qian, Qijun ^c   Fan, Xiaolong ^a,d  

^a LUND UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CONDITIONALLY REPLICATING ADENOVIRUS; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; MEMBRANE COFACTOR PROTEIN; VIRUS FIBER PROTEIN;

ADENOVIRUS; ADENOVIRUS 11; ADENOVIRUS 35; ADENOVIRUS 37; ADENOVIRUS 4; ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROGENY; PROTEIN BINDING; PROTEIN SYNTHESIS; TUMOR XENOGRAFT; VIRUS CELL INTERACTION; VIRUS PARTICLE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; BYSTANDER EFFECT; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; RECEPTORS, VIRUS; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE;

EID: 77954078795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008484     Document Type: Article

References (43)

1. Fox JP, Hall CE, Cooney MK (1977) The Seattle Virus Watch. VII. Observations of adenovirus infections. Am J Epidemiol 105(4): 362-386.
2. Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, et al. (2009) Latent species C adenoviruses in human tonsil tissues. J Virol 83(6): 2417-2428.
3. Heise C, Kirn DH (2000) Replication-selective adenoviruses as oncolytic agents. J Clin Invest 105(7): 847-851.
4. Lichtenstein DL, Wold WS (2004) Experimental infections of humans with wild- type adenoviruses and with replication-competent adenovirus vectors: replica- tion, safety, and transmission. Cancer Gene Ther 11(12): 819-829.
5. Edqvist A, Rebetz J, Jaras M, Rydelius A, Skagerberg G, et al. (2006) Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells. Mol Ther 14(1): 139-148.
6. Wirth T, Zender L, Schulte B, Mundt B, Plentz R, et al. (2003) A telomerase- dependent conditionally replicating adenovirus for selective treatment of cancer. Cancer Res 63(12): 3181-3188.
7. Zhang Q, Chen G, Peng L, Wang X, Yang Y, et al. (2006) Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clin Cancer Res 12(21): 6523-6531.
8. Krasnykh V, Dmitriev I, Navarro JG, Belousova N, Kashentseva E, et al. (2000) Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity. Cancer Res 60(24): 6784-6787.
9. Nilsson M, Ljungberg J, Richter J, Kiefer T, Magnusson M, et al. (2004) Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med 6(6): 631-641.
10. Harrison D, Sauthoff H, Heitner S, Jagirdar J, Rom WN, et al. (2001) Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved-deletion of the viral E1b-19-kD gene increases the viral oncolytic effect. Hum Gene Ther 12(10): 1323-1332.
11. Sauthoff H, Hu J, Maca C, Goldman M, Heitner S, et al. (2003) Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther 14(5): 425-433.
12. Hong SS, Habib NA, Franqueville L, Jensen S, Boulanger PA (2003) Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors. J Virol 77(19): 10366-10375.
13. Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, et al. (2005) Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol 174(11): 7179-7185.
14. Boulanger PA, Puvion F (1973) Large-scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form. Eur J Biochem 39(1): 37-42.
15. Franqueville L, Henning P, Magnusson M, Vigne E, Schoehn G, et al. (2008) Protein crystals in Adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS ONE 3(8): e2894.
16. Norrby E (1969) The structural and functional diversity of Adenovirus capsid components. J Gen Virol 5(2): 221-236.
17. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, et al. (2002) Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 110(6): 789-799.
18. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275(5304): 1320-1323.
19. Hong JS, Engler JA (1991) The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology 185(2): 758-767.
20. Fender P, Ruigrok RW, Gout E, Buffet S, Chroboczek J (1997) Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol 15(1): 52-56.
21. Wang Y, Wang S, Bao Y, Ni C, Guan N, et al. (2006) Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers. J Mol Histol 37(3-4): 153-160.
22. Zhang Y, Bergelson JM (2005) Adenovirus receptors. J Virol 79(19): 12125-12131.
23. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nat Med 9(11): 1408-1412.
24. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, et al. (2003) Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 77(17): 9183-9191.
25. Tuve S, Wang H, Ware C, Liu Y, Gaggar A, et al. (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol 80(24): 12109-12120.
26. Seiradake E, Lortat-Jacob H, Billet O, Kremer EJ, Cusack S (2006) Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J Biol Chem 281(44): 33704-33716.
27. Wu E, Trauger SA, Pache L, Mullen TM, von Seggern DJ, et al. (2004) Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol 78(8): 3897-3905.
28. Arnberg N, Edlund K, Kidd AH, Wadell G (2000) Adenovirus type 37 uses sialic acid as a cellular receptor. J Virol 74(1): 42-48.
29. Shayakhmetov DM, Li ZY, Ternovoi V, Gaggar A, Gharwan H, et al. (2003) The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 77(6): 3712-3723.
30. Marttila M, Persson D, Gustafsson D, Liszewski MK, Atkinson JP, et al. (2005) CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J Virol 79(22): 14429-14436.
31. Kaye SB, Lloyd M, Williams H, Yuen C, Scott JA, et al. (2005) Evidence for persistence of adenovirus in the tear film a decade following conjunctivitis. J Med Virol 77(2): 227-231.
32. Russell WC (2000) Update on adenovirus and its vectors. J Gen Virol 81(Pt 11): 2573-2604.
33. Schaack J (2005) Induction and inhibition of innate inflammatory responses by adenovirus early region proteins. Viral Immunol 18(1): 79-88.
34. Numazaki Y, Shigeta S, Kumasaka T, Miyazawa T, Yamanaka M, et al. (1968) Acute hemorrhagic cystitis in children. Isolation of adenovirus type II. N Engl J Med 278(13): 700-704.
35. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD (1985) Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 312(9): 529-533.
36. Cattaneo R (2004) Four Viruses, Two Bacteria, and One Receptor: Membrane Cofactor Protein (CD46) as Pathogens' Magnet. J Virol 78(9): 4385-4388.
37. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, et al. (1988) Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333(6172): 426-431.
38. Greber UF, Gastaldelli M (2007) Junctional Gating: The Achilles' Heel of Epithelial Cells in Pathogen Infection. Cell Host & Microbe 2(3): 143-146.
39. Chappell JD, Prota AE, Dermody TS, Stehle T (2002) Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber. Embo J 21(1-2): 1-11.
40. Tyler KL, McPhee DA, Fields BN (1986) Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 233(4765): 770-774.
41. Mittereder N, March KL, Trapnell BC (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70(11): 7498-7509.
42. Pring-Akerblom P, Heim A, Trijssenaar FE (1998) Molecular characterization of hemagglutination domains on the fibers of subgenus D adenoviruses. J Virol 72(3): 2297-2304.
43. 2000 Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc, 2001. 218(5): 669-696.